Advances in screening, diagnosis, and treatment of breast cancer

Betty A. Mincey, Edith A. Perez

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Breast cancer is the most common cancer in women in the United States; this year, approximately 215,900 new cases will be diagnosed. Mammography remains the cornerstone of screening, with technologies such as ultrasonography and magnetic resonance imaging having an increasingly defined role. Improved risk assessment and prevention strategies have been implemented, and current research in these areas includes better identification of patients at risk, the use of aromatase inhibitors and other agents to reduce risk, and the use of surrogate markers. Breast cancer staging has been optimized recently; also, local management of breast cancer, adjuvant systemic therapies, and treatment of patients with advanced disease have been evolving. Advances in screening, diagnosis, and treatment of breast cancer continue to influence our approach to patients with this disease. Many improvements have been made as well in supportive care, including increased tolerability of therapy and notable amelioration of disease symptoms.

Original languageEnglish (US)
Pages (from-to)810-816
Number of pages7
JournalMayo Clinic Proceedings
Volume79
Issue number6
StatePublished - 2004

Fingerprint

Breast Neoplasms
Aromatase Inhibitors
Neoplasm Staging
Mammography
Therapeutics
Ultrasonography
Biomarkers
Magnetic Resonance Imaging
Technology
Research
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mincey, B. A., & Perez, E. A. (2004). Advances in screening, diagnosis, and treatment of breast cancer. Mayo Clinic Proceedings, 79(6), 810-816.

Advances in screening, diagnosis, and treatment of breast cancer. / Mincey, Betty A.; Perez, Edith A.

In: Mayo Clinic Proceedings, Vol. 79, No. 6, 2004, p. 810-816.

Research output: Contribution to journalArticle

Mincey, BA & Perez, EA 2004, 'Advances in screening, diagnosis, and treatment of breast cancer', Mayo Clinic Proceedings, vol. 79, no. 6, pp. 810-816.
Mincey, Betty A. ; Perez, Edith A. / Advances in screening, diagnosis, and treatment of breast cancer. In: Mayo Clinic Proceedings. 2004 ; Vol. 79, No. 6. pp. 810-816.
@article{636c54a3986844a2a95a83b5018fdf7b,
title = "Advances in screening, diagnosis, and treatment of breast cancer",
abstract = "Breast cancer is the most common cancer in women in the United States; this year, approximately 215,900 new cases will be diagnosed. Mammography remains the cornerstone of screening, with technologies such as ultrasonography and magnetic resonance imaging having an increasingly defined role. Improved risk assessment and prevention strategies have been implemented, and current research in these areas includes better identification of patients at risk, the use of aromatase inhibitors and other agents to reduce risk, and the use of surrogate markers. Breast cancer staging has been optimized recently; also, local management of breast cancer, adjuvant systemic therapies, and treatment of patients with advanced disease have been evolving. Advances in screening, diagnosis, and treatment of breast cancer continue to influence our approach to patients with this disease. Many improvements have been made as well in supportive care, including increased tolerability of therapy and notable amelioration of disease symptoms.",
author = "Mincey, {Betty A.} and Perez, {Edith A.}",
year = "2004",
language = "English (US)",
volume = "79",
pages = "810--816",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "6",

}

TY - JOUR

T1 - Advances in screening, diagnosis, and treatment of breast cancer

AU - Mincey, Betty A.

AU - Perez, Edith A.

PY - 2004

Y1 - 2004

N2 - Breast cancer is the most common cancer in women in the United States; this year, approximately 215,900 new cases will be diagnosed. Mammography remains the cornerstone of screening, with technologies such as ultrasonography and magnetic resonance imaging having an increasingly defined role. Improved risk assessment and prevention strategies have been implemented, and current research in these areas includes better identification of patients at risk, the use of aromatase inhibitors and other agents to reduce risk, and the use of surrogate markers. Breast cancer staging has been optimized recently; also, local management of breast cancer, adjuvant systemic therapies, and treatment of patients with advanced disease have been evolving. Advances in screening, diagnosis, and treatment of breast cancer continue to influence our approach to patients with this disease. Many improvements have been made as well in supportive care, including increased tolerability of therapy and notable amelioration of disease symptoms.

AB - Breast cancer is the most common cancer in women in the United States; this year, approximately 215,900 new cases will be diagnosed. Mammography remains the cornerstone of screening, with technologies such as ultrasonography and magnetic resonance imaging having an increasingly defined role. Improved risk assessment and prevention strategies have been implemented, and current research in these areas includes better identification of patients at risk, the use of aromatase inhibitors and other agents to reduce risk, and the use of surrogate markers. Breast cancer staging has been optimized recently; also, local management of breast cancer, adjuvant systemic therapies, and treatment of patients with advanced disease have been evolving. Advances in screening, diagnosis, and treatment of breast cancer continue to influence our approach to patients with this disease. Many improvements have been made as well in supportive care, including increased tolerability of therapy and notable amelioration of disease symptoms.

UR - http://www.scopus.com/inward/record.url?scp=2542486358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542486358&partnerID=8YFLogxK

M3 - Article

C2 - 15182098

AN - SCOPUS:2542486358

VL - 79

SP - 810

EP - 816

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 6

ER -